- Home
- HUMAW vs STBA Comparison
HUMAW vs STBA Comparison
Compare HUMAW & STBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMAW
- STBA
- Stock Information
- Founded
- HUMAW 2004
- STBA 1902
- Country
- HUMAW United States
- STBA United States
- Employees
- HUMAW 185
- STBA N/A
- Industry
- HUMAW Biotechnology: Pharmaceutical Preparations
- STBA Major Banks
- Sector
- HUMAW Health Care
- STBA Finance
- Exchange
- HUMAW Nasdaq
- STBA Nasdaq
- Market Cap
- HUMAW N/A
- STBA N/A
- IPO Year
- HUMAW N/A
- STBA N/A
- Fundamental
- Price
- HUMAW $0.37
- STBA $37.33
- Analyst Decision
- HUMAW
- STBA Hold
- Analyst Count
- HUMAW 0
- STBA 1
- Target Price
- HUMAW N/A
- STBA $41.00
- AVG Volume (30 Days)
- HUMAW 14.2K
- STBA 195.6K
- Earning Date
- HUMAW 03-21-2025
- STBA 04-17-2025
- Dividend Yield
- HUMAW N/A
- STBA 3.66%
- EPS Growth
- HUMAW N/A
- STBA N/A
- EPS
- HUMAW N/A
- STBA 3.41
- Revenue
- HUMAW N/A
- STBA $383,756,000.00
- Revenue This Year
- HUMAW N/A
- STBA $5.56
- Revenue Next Year
- HUMAW N/A
- STBA $5.82
- P/E Ratio
- HUMAW N/A
- STBA $10.89
- Revenue Growth
- HUMAW N/A
- STBA N/A
- 52 Week Low
- HUMAW $1.18
- STBA $28.83
- 52 Week High
- HUMAW $1.34
- STBA $45.79
- Technical
- Relative Strength Index (RSI)
- HUMAW N/A
- STBA 43.03
- Support Level
- HUMAW N/A
- STBA $35.87
- Resistance Level
- HUMAW N/A
- STBA $38.21
- Average True Range (ATR)
- HUMAW 0.00
- STBA 0.98
- MACD
- HUMAW 0.00
- STBA -0.01
- Stochastic Oscillator
- HUMAW 0.00
- STBA 54.28
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.